• 한국미생물·생명공학회지
• /
• 제24권1호
• /
• pp.27-36
• /
• 1996

The aim of the present research program was to identify and develop strains of actinomycetes producing antifungal antibiotics which inhibit cell wall biosynthesis. 860 strains of Actinomycetes were isolated from various soil samples. Three isolates, EMS4, EMP22, and L234 were selected as the strains producing antifungal antibiotics inducing abnormal morphology against Penicillium cyclopium, Cryptococcus laurentii, and Aspergillus flavus, respectively. Taxonomic unit characters of the strains were tested and the data were analyzed numerically using TAXON program. EMS4, EMP22, and L234 were indentified to be a member of Streptomyces lavendulae, Streptomyces willmorei, and Streptomyces aburaviensis, respectively.

• 한국식품영양학회지
• /
• 제22권1호
• /
• pp.97-102
• /
• 2009

본 연구에서는 독성이 적고, 활성이 높으면서 안정한 새로운 tyrosinase 저해제를 미생물을 대상으로 얻고자 tyrosinase 저해제를 강하게 분비하는 방선균 F-97을 토양으로부터 분리하였다. 이 균의 기균사는 회색의 나뭇가지형 (tree type)이며, 포자의 끝부분이 유선형으로 회전되어 있고, 포자 표면은 구형의 smooth형으로 분류되었다. 세포벽의 DAP 성분은 LL-DAP이었으며, 세포균체의 당 성분은 검출되지 않았다. 기타 배양학적 및 생리적 특성을 종합한 결과 streptomyces aburaviensis 또는 근연균으로 추정된다.

• 한국미생물·생명공학회지
• /
• 제51권4호
• /
• pp.474-483
• /
• 2023

Members of the genus Streptomyces produce more than 70% of antibiotics. The rise in antibiotic resistance globally enhanced the search for novel species with the ability to produce new bioactive compounds. This study was initiated to investigate different regions in Jordan for previously uncultured and rare Streptomyces species capable of producing novel antimicrobial compounds especially active against bacteria resistant to antibiotics. A total of 191 Streptomyces strains were isolated from 26 soil samples collected from different geographic regions in Jordan. Isolates were characterized based on colony and cellular morphology as well as using 16S rRNA gene sequencing. These isolates were screened for their ability to produce antibiotics by the perpendicular-cross streak method, and then tested by well diffusion method against tested pathogens. Fifty-four isolates showed potential to produce antimicrobial products especially active against resistant bacteria, 20.1% of the isolates showed inhibitory effect against Staphylococcus aureus, 16.9% against clinical MSSA strains, and 18.0% against MRSA: whereas only 4.2% against Esherichia coli, 3.2% against Klebsiella pneumonia, 2.7% against Pseudomonas aeruginosa, and 10.0% against clinical Candida albicans. Three isolates were selected for further identification due to their antibacterial activity against S. aureus, MRSA, and MSSA. These isolates were identified as follows; Streptomyces aburaviensis DSa3, Streptomyces alboniger SAb7 and Streptomyces misionensis ZAb2, based on cultural, biochemical characteristics and molecular analysis of the 16S rRNA.